Original Literature | Model OverView |
---|---|
Publication
Title
TIR domain-containing adaptors define the specificity of TLR signaling.
Affiliation
Department of Host Defense, Research Institute for Microbial Diseases, OsakaUniversity, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
Abstract
The concept that Toll-like receptors (TLRs) recognize specific molecularpatterns in various pathogens has been established. In signal transduction viaTLRs, MyD88, which harbors a Toll/IL-1 receptor (TIR)-domain and a death domain,has been shown to link between TLRs and MyD88-dependent downstream eventsleading to proinflammatory cytokine production and splenocyte proliferation.However, recent studies using MyD88-deficient mice have revealed that some TLRspossess a MyD88-independent pathway, which is represented by interferon(IFN)-beta production induced by LPS stimulation. This indicates that additionalsignaling molecules other than MyD88 exist in the TLR signaling pathway. Indeed,two additional TIR domain-containing adaptors, TIRAP/Mal and TRIF, have recentlybeen identified. Both define the specific biological responses of each TLR.
PMID
14698224
|
Entity
Process
IFN-beta
--
G010228
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93217
10
infinite
0
TRANSFAC | G010228 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m37
10
infinite
0
TRANSPATH | MO000000058 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
TIRAP
--
MO000022528
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6810
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000022528 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
IL-12B
--
MO000043607
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m21351
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000043607 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
peptidoglycan
--
e11
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m11
0
infinite
0
--
peptidoglycan:TLR2
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
LPS:TLR4
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
Flagellin
--
e14
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m14
0
infinite
0
--
Flagellin:TLR5
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m15
0
infinite
0
--
Diacylated lipoprotein
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
Diacylated lipoprotein:TLR6
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
Imidazoquinoline
--
e18
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
Imidazoquinoline: TLR7
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
R-848
--
e20
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
R-848:TLR7
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
CpGDNA
--
e22
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m22
0
infinite
0
--
CpGDNA:TLR9
--
e23
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m23
0
infinite
0
--
triacylated lipoprotein:TLR1:MyD88
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
peptidoglycan:TLR2:MyD88
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
dsRNA:TLR3:MyD88
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
LPS:TLR4:MyD88
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
Flagellin:TLR5:MyD88
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
CpGDNA:TLR9:MyD88
--
e29
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Diacylated lipoprotein:TLR5:MyD88
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
imidazoquinoline:TLR7:MyD88
--
e31
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m31
0
infinite
0
--
R-848:TLR7:MyD88
--
e32
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
IRAK-4(active}
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m33
10
infinite
0
TRANSPATH | MO000039077 |
--
IRAK1
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
IRAK1{active}
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
TRAF6{active}
--
e36
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
NF-kappaB{active}
--
e37
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38
10
infinite
0
TRANSPATH | MO000000058 |
--
TIRAP:MyD88
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
TLR4:TIRAP
--
e39
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
MALP-2
--
e40
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m41
0
infinite
0
--
MALP-2:TLR2
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
IRF-3:IRF-3
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
IRF-3:IRF-3
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
IP-10
--
e45
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m46
0
infinite
0
--
GARG-16
--
e46
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m47
0
infinite
0
--
IRG-1
--
e47
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m48
0
infinite
0
--
TLR3:TRIF
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m49
0
infinite
0
--
TRIF:IRF-3
--
e49
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m63
0
infinite
0
--
Triacylated Lipoprotein
--
e5
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
triacylated lipoprotein:TLR1
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
Type I IFN
--
e63
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m64
0
infinite
0
--
Type I IFN
--
e64
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m65
0
infinite
0
--
TRAM:TIRAP
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
TRAM:TRIF
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
IKK-i
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
Ikk-i:TRIF
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
TBK1:TRIF
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
IFN-beta
--
e71
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m72
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*m3963*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m19828*m22*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m6*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c37 : 1
m12*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p11
p13
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c38 : 1
m19314*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m13*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m15*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m17*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m23*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m19*m1572*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m1572*m21*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m3964*m11*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
p20
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c57 : 1
stoichiometry:c59 : 1
m17258*m29*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m24*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m25*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m26*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m27*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m28*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m30*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m31*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m32*m17258*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m29*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p2
p3
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m24*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m25*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m26*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m27*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m28*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m30*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m31*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m32*m34*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m29*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p39
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m24*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p2
p4
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
p20
p40
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m25*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
stoichiometry:c122 : 1
m26*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m27*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m28*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m30*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
stoichiometry:c134 : 1
m31*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p46
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m32*m183*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p47
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m36*m37*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m35*m37*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p20
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m33*m37*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c13 : 1
stoichiometry:c15 : 1
m3966*m14*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
p50
p50
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c157 : 1
m93309*m1572*0.1
nodelay
--
0
PMID: 14698224 Macrophages from MyD88-deficient mice are completely defective in the production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, and IL-12 p40 in response to bacterial components.
p50
p51
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c152 : 1
stoichiometry:c156 : 1
m93248*m1572*0.1
nodelay
--
0
PMID: 14698224 Macrophages from MyD88-deficient mice are completely defective in the production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, and IL-12 p40 in response to bacterial components.
p50
p52
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c153 : 1
stoichiometry:c158 : 1
m93364*m1572*0.1
nodelay
--
0
PMID: 14698224 Macrophages from MyD88-deficient mice are completely defective in the production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, and IL-12 p40 in response to bacterial components.
p50
p53
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m93589*m1572*0.1
nodelay
--
0
PMID: 14698224 Macrophages from MyD88-deficient mice are completely defective in the production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, and IL-12 p40 in response to bacterial components.
p54
p54
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m6810*m1572*0.1
nodelay
--
0
PMID: 14698224 Furthermore, epitope-tagged TIRAP interacted directly with MyD88 and the TIR domain of TLR4 but not TLR9, suggesting that, unlike MyD88 which participates in all of the TLR and IL-1 receptor signaling pathways, TIRAP is an adaptor molecule specific for TLR4 signaling.
p54
p55
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c162 : 1
stoichiometry:c164 : 1
m6810*m3961*0.1
nodelay
--
0
PMID: 14698224 Furthermore, epitope-tagged TIRAP interacted directly with MyD88 and the TIR domain of TLR4 but not TLR9, suggesting that, unlike MyD88 which participates in all of the TLR and IL-1 receptor signaling pathways, TIRAP is an adaptor molecule specific for TLR4 signaling.
p56
p56
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c165 : 1
stoichiometry:c167 : 1
m93309*m13*0.1
nodelay
--
0
PMID: 14698224 Regarding cytokine production, LPS stimulation of wildtype macrophages resulted in the production of TNF-alpha, IL-6 and IL-12 p40 in a dose-dependent manner, whereas the production of these cytokines was completely abolished in TIRAP-deficient cells.
p56
p57
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m93248*m13*0.1
nodelay
--
0
PMID: 14698224 Regarding cytokine production, LPS stimulation of wildtype macrophages resulted in the production of TNF-alpha, IL-6 and IL-12 p40 in a dose-dependent manner, whereas the production of these cytokines was completely abolished in TIRAP-deficient cells.
p56
p58
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c173 : 1
stoichiometry:c172 : 1
m93589*m13*0.1
nodelay
--
0
PMID: 14698224 Regarding cytokine production, LPS stimulation of wildtype macrophages resulted in the production of TNF-alpha, IL-6 and IL-12 p40 in a dose-dependent manner, whereas the production of these cytokines was completely abolished in TIRAP-deficient cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m3964*m41*0.1
nodelay
--
0
PMID: 14698224 Stimulation with MALP-2, a TLR2 ligand, showed NF-KappaB activation and MAPK phosphorylation in wild-type cells, but these were profoundly inhibited in TIRAP-deficient cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m16*m3987*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
p60
p60
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c179 : 1
m42*m37*0.1
nodelay
--
0
PMID: 14698224 Stimulation with MALP-2, a TLR2 ligand, showed NF-kappaB activation and MAPK phosphorylation in wild-type cells, but these were profoundly inhibited in TIRAP-deficient cells.
p61
p61
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c181 : 1
stoichiometry:c182 : 1
m42*m1812*0.1
nodelay
--
0
PMID: 14698224 Stimulation with MALP-2, a TLR2 ligand, showed NF-kappaB activation and MAPK phosphorylation in wild-type cells, but these were profoundly inhibited in TIRAP-deficient cells.
p62
p62
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c183 : 1
stoichiometry:c184 : 1
stoichiometry:c185 : 1
m13*m977*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c187 : 1
m44*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m45*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m45*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m45*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
m45*0.1
nodelay
--
0
PMID: 14698224, 11070172, 10607756 IRF3 is a key transcription factor for LPS-mediated expression of IFN-beta and IRGs Activated IRF3 forms a homodimer after LPS stimulation and translocates into the nucleus to switch on the induction of IFN-beta and other IRGs
p68
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m1572*m37*0.1
nodelay
--
0
PMID: 14698224 As reported previously, overexpression of MyD88 or TIRAP in 293 cells strongly induced NF-kappaB activation as detected by a luciferase-mediated reporter assay
p68
p69
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m6810*m37*0.1
nodelay
--
0
PMID: 14698224 As reported previously, overexpression of MyD88 or TIRAP in 293 cells strongly induced NF-kappaB activation as detected by a luciferase-mediated reporter assay
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m18*m19940*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
p70
p70
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
stoichiometry:c204 : 1
m18998*m37*0.1
nodelay
--
0
PMID: 14698224 Overexpression of TRIF activated NF-kappaB, albeit at a low level compared with MyD88- or TIRAP-induced activation
p71
p71
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c206 : 1
m18998*0.1
nodelay
--
0
PMID: 14698224 TRIF overexpression culminated in activation of not only the NF-kappaB-responsive element but also the IFN-beta promoter.
p72
p72
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m18998*m3965*0.1
nodelay
--
0
PMID: 14698224 Coimmunoprecipitation analysis revealed that TRIF associated with the TIR domain of TLR3, indicating that TRIF may recognize TLR3 through homophilic interaction TRIF interacted with TLR3 through the TIR domain and endogenous IRF3.
p72
p73
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
m18998*m977*0.1
nodelay
--
0
PMID: 14698224 Coimmunoprecipitation analysis revealed that TRIF associated with the TIR domain of TLR3, indicating that TRIF may recognize TLR3 through homophilic interaction TRIF interacted with TLR3 through the TIR domain and endogenous IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
stoichiometry:c215 : 1
m23*m64*0.1
nodelay
--
0
PMID: 14698224 However, the production of type I interferon from certain cell types is stimulated by activation of TLR9 signaling but not by that of TLR2
p75
p75
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c216 : 1
stoichiometry:c217 : 1
stoichiometry:c218 : 1
m6810*m19005*0.1
nodelay
--
0
PMID: 14698224 In addition, the latter group found that TRAM/TIRP associated with other TIR domain-containing adaptors, including TIRAP and TRIF, but not with MyD88.
p75
p76
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c220 : 1
stoichiometry:c221 : 1
m18998*m19005*0.1
nodelay
--
0
PMID: 14698224 In addition, the latter group found that TRAM/TIRP associated with other TIR domain-containing adaptors, including TIRAP and TRIF, but not with MyD88.
p77
p77
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c223 : 1
stoichiometry:c224 : 1
m68*m977*0.1
nodelay
--
0
PMID: 14698224, 12692549, 12702806 Recently, two groups reported that IKK-I/IKK-¦Å and TBK1/T2K act as molecules for mediating IRF3 phosphorylation
p77
p78
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c225 : 1
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m3902*m977*0.1
nodelay
--
0
PMID: 14698224, 12692549, 12702806 Recently, two groups reported that IKK-I/IKK-¦Å and TBK1/T2K act as molecules for mediating IRF3 phosphorylation
p79
p79
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m3902*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m20*m19940*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m68*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
p79
p81
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c232 : 1
stoichiometry:c233 : 1
m3902*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c235 : 1
m68*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
p83
p83
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c237 : 1
stoichiometry:c238 : 1
m3902*m37*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
p83
p84
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c239 : 1
stoichiometry:c240 : 1
stoichiometry:c241 : 1
m68*m37*0.1
nodelay
--
0
PMID: 14698224, 12692549 Surprisingly, overexpression of both molecules led to strong activation of the IFN-beta and RANTES promoters as well as NF-kappaB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c242 : 1
stoichiometry:c243 : 1
stoichiometry:c246 : 1
m18998*m68*0.1
nodelay
--
0
PMID: 14698224, 12692549 TRIF bound to IKKI/ IKK-¦Å and TBK1/T2K through regions other than the TIR domain
p85
p86
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c245 : 1
stoichiometry:c247 : 1
m18998*m3902*0.1
nodelay
--
0
PMID: 14698224, 12692549 TRIF bound to IKKI/ IKK-¦Å and TBK1/T2K through regions other than the TIR domain
p87
p87
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c248 : 1
stoichiometry:c250 : 1
stoichiometry:c249 : 1
m101705*m13*0.1
nodelay
--
0
PMID: 14698224 Instead, LPS-mediated production of type I interferons, such as IFN-beta and IFN-alpha4, was perturbed in Tyk2-deficient mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c251 : 1
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m93217*m13*0.1
nodelay
--
0
PMID: 14698224 Instead, LPS-mediated production of type I interferons, such as IFN-beta and IFN-alpha4, was perturbed in Tyk2-deficient mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c255 : 1
m38*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m18*0.1
nodelay
--
0
PMID: 14698224 To date, 10 TLRs (TLR1-TLR10) have been reportedly encoded in the human genome, and at least one ligand has been identified for each TLR, except for TLR8 and TLR10: triacylated lipoprotein for TLR1; peptidoglycan, the major gram-positive bacterial cell wall component, for TLR2; double-stranded RNA, which is considered to be generated in the lifecycle of RNA viruses, for TLR3; lipopolysaccharide (LPS), a gram-negative cell wall component, for TLR4; flagellin, a component of bacterial flagella, for TLR5; diacylated lipoprotein for TLR6; imidazoquinoline, an anti-viral drug, and its derivative R-848, for TLR7; and bacterial unmethylated CpG DNA for TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c256 : 1
stoichiometry:c257 : 1
m38*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c259 : 1
m38*0.1
nodelay
--
0
PMID: 14698224, 11923871, 12297423, 12620219 , 11983155 , 12467243 MyD88, a common adaptor protein also harboring a TIR domain, is associated with the TIR domain of TLRs, and leads to the activation of IRAK-1/4 and TRAF-6, culminating in the activation of NF-kappaB, a transcription factor crucial for the expression of pro-inflammatory cytokines and various mediators
p92
p92
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c261 : 1
stoichiometry:c270 : 1
stoichiometry:c262 : 1
m13*m37*m6438*0.1
nodelay
--
0
PMID: 14698224, 10435584 Although the activation of NF-KappaB and MAPK through almost all of the TLRs is abolished in MyD88-deficient cells, the TLR4 ligand LPS stimulation still activates NF-KappaB and MAPK in MyD88-deficient cells, but with delayed kinetics compared with those of wild-type cells PMID: 14698224 LPS stimulation activated the NF-KappaB responsive reporter in cells transfected with both TLR4 and MD-2,
p92
p93
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c263 : 1
stoichiometry:c264 : 1
stoichiometry:c265 : 1
stoichiometry:c266 : 1
m13*m1812*m18998*0.1
nodelay
--
0
PMID: 14698224, 10435584 Although the activation of NF-KappaB and MAPK through almost all of the TLRs is abolished in MyD88-deficient cells, the TLR4 ligand LPS stimulation still activates NF-KappaB and MAPK in MyD88-deficient cells, but with delayed kinetics compared with those of wild-type cells
p94
p94
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c267 : 1
stoichiometry:c268 : 1
stoichiometry:c269 : 1
m19314*m37*0.1
nodelay
--
0
PMID: 14698224, 11607032 TLR3 has also been shown to utilize the MyD88-independent pathway, since poly(I:C)-induced NF-KappaB activation and maturation of dendritic cells were observed normally in MyD88-deficient mice
p95
p95
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c271 : 1
stoichiometry:c272 : 1
m19314*0.1
nodelay
--
0
PMID: 14698224, 12054664 293 cells stably transfected with TLR3 showed poly(I:C) stimulation-dependent activation of NF-KappaB and the IFN-beta promoter
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--